Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Atrys Health SA ( (ES:ATRY) ) has issued an announcement.
Atrys Health, S.A. announced that its subsidiary, Bienzobas Salud, continues to enhance its oncological advisory services by adhering to the European Society for Medical Oncology’s standards for sustainable cancer care. This approach ensures that patients receive appropriate treatments based on clinical benefits while maintaining cost-effectiveness, supporting both public and private healthcare systems in Spain.
More about Atrys Health SA
Atrys Health, S.A., through its subsidiary Bienzobas Salud, S.L.U., specializes in oncological advice, leveraging over 20 years of experience. The company aligns its services with international clinical guidelines and drug evaluation standards to provide sustainable and equitable cancer care.
YTD Price Performance: -10.40%
Average Trading Volume: 981
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: €234M
For detailed information about ATRY stock, go to TipRanks’ Stock Analysis page.